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This thesis will investigate the effect that Alzheimer’s disease, blindness, cancer, and 
Parkinson’s disease have on natural circadian rhythms.  Circadian rhythms are the biological 
cycles within our bodies that repeat themselves which can be observed in correspondence to a 
relative time frame of 24 hours.  These cycles can be influenced by a wide variety of factors, 
both internal and external, such as the daily transitions between daylight and nightfall, an 
individual's diet or hunger tendencies, and the daily number of hours of sleep that a person gets. 
Should any of these cycles become disrupted, the result may be a deterioration of an array of 
physiological processes.  In conjunction with pre-existing or pre-diagnosed diseases or 
conditions, one’s quality of life generally becomes worsened when paired with disrupted 
circadian rhythms.  This thesis will further investigate and explain the relationship between the 
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Since the beginning of time, all living organisms on planet Earth were faced with the 
need  to change and adapt over time and varying conditions in order to survive. Many of these 
organisms were able to progress and evolve to their modern forms due to their beneficial traits or 
natural genetic advantages.  Although unaware then of what we know now, scientists would 
come to learn that some of the most important adaptive behaviors surrounded circadian cycles. 
For instance, the ability of sustaining a properly synchronized circadian cycle would allow an 
organism the ability and knowledge to anticipate different shifts that would occur for certainty 
with the passage of each day.  These shifts could be as simple as recognition of fluctuations 
between periods of daylight and nightfall, or as complex as developing an understanding of 
seasonal and weather-related modifications.  Ultimately, the thread that ties this together was the 
intuitive ability to both process and interpret natural surroundings, and to store these findings in 
one’s memory to properly prepare for the future.  
Without the scientific discoveries and experiments of the past, we wouldn't have nearly 
the same understanding or developed technology that, in present day, have allowed us to learn 
more about our world and surroundings.  This statement also holds true in regards to the field of 
chronobiology, a subdivision of general biology with  a greater emphasis placed on inspecting 
and analyzing cyclical patterns and phenomena.  For instance, some of the origins of studying 
biological rhythms date all the way back to the early 1700’s.  Specifically, in 1729, French 
scientist Jean-Jacques d’Ortous de Mairan published a monograph in which he explained his 
examinations of the ​Mimosa pudica​ plant.  He observed that even during periods which were 
completely absent of light, the plants leaves would continue to move and proceed to unfold in 
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their typical fashion.  From these observations, de Mairan suggested that the movement acted as 
a result of some internal mechanism and not as a response to the amount of sunlight that the plant 
was receiving.  Just a few hundred years later, this phenomenon would become better identified 
and formally referred to as an “internal clock”, the driving force of actions among all living 
organisms (Vitaterna et al., 2001). 
Towards the end of the 19th century and into the start of the 20th century, Austrian 
neurologist Constantin Von Economo made an important discovery which played a pivotal role 
in identifying relevant anatomical regions responsible for patterns of sleep and wakefulness. 
While conducting research and investigating the pathology of ​encephalitis lethargica​, Von 
Economo ultimately proposed the idea that a sleep center existed within the brain, in the anterior 
hypothalamus, with a comparable wake center existing as well, within the posterior 
hypothalamus.  Although these were simply Von Economo’s theories based off of observed 
correlations, these ideas were subsequently proven to be true following a study conducted by 
researcher and neuroanatomist Walle Nauta.  Utilizing a population of rats as his experimental 
subjects, Nauta was able to prove patterns of prolonged wakefulness as a result of a lesion to the 
anterior hypothalamus, as well as similar patterns of extended sleep in the presence of a lesion to 
the posterior hypothalamus.  These crucial discoveries not only provided proof of Von 
Economo’s theories, but also allowed us to pinpoint that both sleep and wakefulness were 
somehow driven by or related to the hypothalamic region of the brain (Moore, 2007).  
Another crucial scientific discovery was made by biologist Curt Richter while conducting 
his Ph.D. thesis which studied biological clocks within the body and their impact on behavior. 
Conducting a lesion study on a population of lab rats, Richter was able to conclude that the rats 
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with hypothalamic lesions experienced a loss of rhythms related to both rest and activity.  The 
evidence collected from this study supported the inference that the hypothalamus in general 
contained the “master clock” among rats, as well as other organisms with similar anatomy 
(Moore, 2007; Schulkin et al., 1994). 
Additionally, throughout the 1950’s and 1960’s, continued experimentation and research 
related to the brain stimulated the development of more sophisticated and refined technology. 
For example, the creation and use of the encephalogram (EEG) allowed researchers to measure 
and record electrical activity conducted within the brain by attaching electrodes to the scalp. 
Likewise, there was the development of an anatomical method of tracing neurological pathways 
of the brain which provided scientists with the ability to study the networks of neuroactive 
peptides and various chemicals produced by the brain including GABA, glutamate, and 
monoamine neurotransmitters (Moore, 2007).  On the research front, biologist Colin Pittendrigh 
and fellow biologist and physician Jürgen Aschoff conducted studies on fruit flies and humans, 
respectively, which led to the identification of circadian rhythmicity, leading to Pittendrigh and 
Aschoff commonly being recognized as the co-founders of the field of chronobiology (Vitaterna 
et al., 2001). 
Before examining the effects that the various diseases previously mentioned had on 
circadian rhythms, it is important to have a fundamental understanding of exactly what circadian 
rhythms are, and the impact that they have on the internal framework of living organisms. 
Following that, we will examine the crucial main components and primary biological pathway 
for conducting these signals.  Circadian rhythms can be mental, behavioral, or physical shifts, 
and are an organism’s primary responses to fluctuation periods between daylight and darkness in 
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one’s own environment.  Circadian rhythms are endogenous in nature, meaning that they are 
developed internally within an organism.  Any factor impacting circadian rhythms which 
originates outside of the organism’s body is exogenous, or known as a zeitgeber, and can include 
various environmental cues like light, temperature, and even the seasons.  While their origins are 
still unclear, many scientists hypothesize that organisms developed these rhythms as products of 
one main regulatory internal clock, constantly evolving to provide protection or advantages.  The 
main regulatory clock of the human body, also commonly referred to as the “master clock” is the 
suprachiasmatic nucleus (SCN) which is located within the hypothalamus, the area of the brain 
that forms a connection between the nervous and endocrine systems.  It consists of 
approximately 20,000 neurons and is responsible for overseeing all mechanisms and rhythms for 
all cells of the human body.  The SCN itself is connected to the optic nerve, allowing for its 
ability to detect the amount of visual brightness perceived. Additionally, it allows for active 
responses to shifts between periods of both brightness and darkness from the environment 
(“Circadian Rhythms”, 2017). 
All of these components play a significant role in the transmission of perceived stimuli 
from an organism’s surroundings to be processed and expressed as rhythmic patterns.  One of the 
main factors impacting circadian rhythms is light, and whether or not it is present in the 
environment and surroundings.  This is where the pathway of transmission is essentially 
initiated.  When light is present, the organism’s eyes receive the light initially through the lens, 
which is channeled through thick vitreous humor and directed towards the back of the eye known 
as the retina.  Beyond the rows of rods and cones which process the color and definition of what 
we view, another row of crucial cells exists within the retina.  These cells are called 
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photosensitive retinal ganglion cells, a specific kind of neuron, and their function is to detect the 
level of brightness of what we are seeing.  These cells are connected to and feed the input to the 
optic nerve, acting as a conduit between the eyes and the brain.  The information is then 
delivered directly to the SCN, the body’s master clock.  From this point, the SCN decides based 
on the received information how to delegate and what to transmit to the other miniature clocks 
controlling the other cells of the body.  In this particular example, the presence of light acted as 
the stimuli to engage the pathway, indicating the body needs to be in an alert state in order to 
function.  For this scenario, the SCN will communicate to the other cells to increase blood 
pressure and simultaneously decrease the production of the chemical melatonin.  Melatonin is a 
hormone commonly associated with inducing the sensation of sleep.  Contrastingly, at the end of 
a day when light starts to fade from one’s surroundings, the body needs to prepare for rest, and 
the SCN reacts appropriately, instructing for increased production of melatonin.  This cycle, 
being dependent on the fluctuation periods of lightness and darkness and having an approximate 










Alzheimer’s Disease (AD) 
Alzheimer’s is a very common form of dementia and accounts for approximately 60-80 
percent of all dementia cases.  This particular disease impacts and hinders one’s mind and 
behaviors.  The majority of the affected population are typically of age 65 or older, however 
younger adults may also suffer from early-onset Alzheimer’s and are typically diagnosed in their 
40’s or 50’s.  AD is a progressive disease, meaning that the amount of overall physiological 
deterioration increases over time.  With respect to other diseases and illnesses, AD is the sixth 
leading cause of death within the United States alone.  Depending on the individual, in 
combination with both age and lifestyle, an affected person can survive anywhere between 4 and 
20 years with the disease.  Currently, there is no cure that exists, but researchers continue to 
study the disease in hopes of one day providing a true remedy. 
Due to its progressive nature, AD is generally recognized as a sequence of three general 
stages: mild AD/ early stage, moderate AD/ middle stage, and severe AD/ late stage.  During the 
mild AD phase, the affected individual is still likely able to function mostly independently. The 
symptoms of the disease may not yet be apparent to those other than close friends or family 
members.  Typical difficulties around this stage include trouble recalling recently learned 
information, misplacing valuable objects, struggles when searching for a proper word or name, 
and increased difficulty in planning or organizing.  Next, the moderate AD phase, usually the 
longest stage of the three, can last for several years. An individual at this stage can still 
participate in some activities of daily living but with assistance. Typical symptoms at this phase 
may include increased mood swings, greater tendencies to wander or get lost, shifts in sleeping 
patterns, difficulty controlling one’s bladder, and forgetfulness of personal history or events.  In 
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the final stage, also known as late stage AD, an individual requires round-the-clock supervision 
and aid with both daily and personal tasks. These individuals may also have increased difficulty 
in verbal communication, swallowing, physical ability, and unsubstantiated feelings or 
suspicions towards friends and family.  In typical fashion of many different diseases, the range or 
severity of symptoms may differ from individual to individual, and theoretically no two 
individuals will suffer from exactly the same set or intensity of symptoms.  Although no cure 
exists to save an individual from this disease, some treatments do exist that can reduce the 
severity of some of the previously listed symptoms. This could possibly provide the individual 
with less discomfort, as well as an improved quality of life. 
AD impacts the brain by making microscopic changes before any signs of the 
characteristic memory loss are even apparent.  This specific period of time is referred to as 
‘preclinical Alzheimer’s disease’ and can last for several years.  As a typical sign of aging, most 
individuals will develop small structures known as plaques and tangles. Plaques are composed of 
beta-amyloid protein fragment deposits which accumulate between nerve cells, and typically 
appear as round, dark disc shapes.  Tangles are made up of twisted tau protein fibers which also  
        Temporal cortex of a patient with AD, 100x magnification (Perl, 2010) 
 Plaques are identified by the black arrows, a tangle identified by the red arrow. 
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gather within cells, and appear as dark, teardrop-like shapes.  Although these two different 
structures can be commonly found in majority of the aging population, those with Alzheimer’s 
develop them in more predictable patterns, with emphasis placed on their location near the 
memory centers of the brain (“What Is Alzheimer’s?”, 2018). 
When looking at the brain’s morphology as impacted by the disease over time, it is 
important to note a gradual shrinking.  As the disease progresses within the body, the main cells 
targeted are the neurons of the brain.  The neurons gradually become damaged and defective, and 
start to die.  The deterioration specifically starts in the hippocampus, the brain center responsible 
for learning and memory.  As the cells continue to degenerate, the brain’s mass also shrinks as a 
result of general substantial tissue loss.  The figures below depict a comparison of a healthy brain 
with one affected by AD. 
  A brain without AD    A brain in advanced stage AD  How the two brains compare 
(“Brain Tour Part 2: Alzheimer’s Effect”, 2018) 
 
The first study pertaining to AD also highlights a unique characteristic and symptom of 
the disease, sundowning.  Sundowning is a phenomenon generally describing heightened 
intervals of active behavioral symptoms, especially during afternoon and evening periods in a 
day.  In addition to exploring the impact of sundowning, the goal of this study was to establish 
10 
what modifications are made on circadian cycles when paired with the presence of AD.  In the 
first study the researchers explain that circadian rhythmicity generally can be observed by 
impacting body temperature, heart rate, secretion of certain hormones, red blood cell production, 
and others.  They then proceed to state that when compared to their healthy counterparts, the 
affected elderly population typically experienced the greatest amount of total daily activity 
during the evening, likely attributed to the effects of sundowning syndrome.  
The study consisted of a total of 25 male patients from a dementia study unit at one of the 
Department of Veteran Affairs’ hospitals.  These men had a collective mean age of 71 years old, 
with a range from 60-88, and a mean diagnosis period of 11 years.  All of these men were noted 
as having some degree of neurological deterioration, with some cases more severe than others. 
Some of the patients with more severe cases were non ambulatory, and the remainder able to 
walk.  None of these subjects received either sedatives nor antipyretic medications within 24 
hours prior to recording any results.  Additionally, there were nine healthy adult males that were 
observed as controls.  These men had a mean age of 73.4 years, ranging from 67-83, with no 
history of neurological disorders and no medications.  Both the patients and the healthy control 
individuals were studied at the same time in order to prevent any external seasonal impact on 
behavior.  In order to keep other factors consistent and prevent any bias, all participants of the 
study had fixed scheduled mealtimes and regulated periods of when the lights were kept on, from 
6:00 in the morning until 10:00 in the evening for the duration of the study.  The healthy 
individuals were housed in a research ward of the hospital and were allowed to rest and sleep as 
they normally would.  The participants were instructed to wear portable activity monitors, worn 
in a vest pocket positioned at waist level, in order to record pertinent data.  ​Relative activity 
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levels and core body temperatures were tracked by a combination of the monitors and other 
methods, which reported data back to researchers every 5 minutes over the course of a 72 hour 
period.  In conjunction with the quantitative recorded data, staff members of the hospital were 
asked to evaluate the degree of sundowning behavior they observed in the subjects, as well as the 
frequency of sleep-wake disturbances.  
After comparing the results of the affected individuals and the control subjects, the 
researchers were able to draw a few conclusions.  One of the important conclusions was that 
patients with AD generally displayed greater nocturnal activity, as well as decreased daily motor 
activity when compared to control subjects.  From the actual recorded results, in terms of 
locomotor activity relative to a 24 hour clock, patients with AD averaged an acrophase time of 
16.92.  Specifically, the average among the ambulatory patients was 16.38 and nonambulatory 
17.46.  This means that the peak point of their activity occurred at approximately 5:00 in the 
afternoon, while the control subjects averaged an acrophase of activity at approximately 1:00 in 
the afternoon.  This was an important discovery because it supported the idea that individuals 
affected by AD may also exhibit signs of sundowning syndrome, and further explained why 
these individuals had increased nocturnal tendencies in terms of activity.  It is also important to 
note that these findings may suggest that as the disease progresses, the greater the impact on the 
acrophase of activity.  Additionally, the researchers concluded that patients with AD generally 
had slightly higher average core body temperatures (37.2 degrees celsius) compared to  control 
subjects (36.9 degrees celsius).  The core body temperature would likely be higher in patients 
with AD because the interaction of the disease pathology with the brain disrupts the 
hypothalamus which acts as the body’s thermostat.  Additionally, it is also typical of patients 
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with AD to secrete lower quantities of melatonin, which could also be related to the slightly 
raised temperatures.  With the presence of melatonin as the body prepares to sleep, the 
hypothalamus typically responds by cooling the body down, and therefore reducing the 
temperature slightly lower than standard. 
Substantial observations were made from this study to support the idea that as AD 
progresses within the body, it is able to disrupt more of the natural processes typically regulated 
by the hypothalamus.  The important functions mentioned in this particular study were the 
amount of daily activity and acrophases suggesting possible sundowning, as well as the 
regulation of core body temperature.  It was concluded that on account of both of these 
processes, affected patients with AD displayed increased activity during late hours and higher 
body temperatures when compared to control subjects (Volicer et al., 2001).  While this specific 
study was very thorough in its experimentation and attempt to reduce as much bias as possible, 
one necessary critique would be that of the environment it which it was conducted.  It is possible 
that the hospital routines and environment may have had some impact on the circadian cycles 
observed, however this cannot necessarily be proven.  For instance, the AD patients, being 
residents of the hospital, may have already developed modified internal patterns in order to 
acclimate to hospital cycles and procedures on a permanent basis.  This would not be the case for 
the control subjects who live normal lives outside of the study, with standard and unaltered 
internal cycles.  Despite this, the hospital as an environment was a necessary component for this 
study so that the patients with AD could receive necessary care and supervision that comes with 
progressed stages of the disease.  
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The second study focuses more on the general impact of AD on sleep-wake cycles.  ​The 
subjects for this study consisted of 28 male patients from a dementia study unit of a Department 
of Veteran Affairs’ hospital.  These men had a collective mean age of 71 years old, with a range 
from 61-82, and a mean duration of 10 years of being diagnosed with AD.  These subjects were 
described as being quite cognitively impaired, unable to walk, communicate, or conduct 
activities of daily living without assistance from hospital staff.  Other than AD, the hospitalized 
study individuals did not suffer from any other forms of illness, and did not receive antipyretic 
medications within a 24 hour period before recording results.  For comparison, the study also 
included ten control subjects, specifically eight males and two females, with an average age of 
73, ranging from 67-80.  These individuals also did not have any illnesses, nor mental deficits, 
and were not taking any medications prior to the study being conducted.  The two groups were 
studied at the same time to prevent any external environmental bias, were regulated by the same 
amount of time in artificial lighting, and were fed on identical schedules.  Beyond these 
parameters,  AD patients received nursing care twice a day, while control subjects were allowed 
to live normal lives within the confines of the research wing.  To record data,  participants were 
asked to wear an activity monitor strapped to their ankle.  The device would record counts of 
activity at five minute intervals over the span of the 72 hour study.  The researchers also used 
rectal thermometers paired with an ambulatory recorder in order to take core body temperatures 
of the participants.  
When analyzing the data, in order to compensate for the two groups which varied in size, 
the researchers took the relevant mean values from each independent population and conducted 
an unpaired ​t​ test to better compare the values between the affected participants and controls. 
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The researchers were able to reach several informative conclusions.  No correlation was recorded 
between the ages of the participants with AD and the duration of the illness within the body. 
This means that one of the relatively younger AD participants may have more abnormally shifted 
cycles and acrophases than an older patient from the study who might have been affected by the 
disease for a longer period of time.  Additionally, when compared to the controls, the AD 
patients displayed overall lower mean daily locomotor activity and increased nocturnal activity, 
characteristics consistent in individuals affected by the disease.  The AD patients were overall 
less active than the controls, and had recorded acrophases lagging approximately 4.5 hours after 
the mean acrophase among the controls, as displayed by the figure below. 
 
Another important detail to mention was that the researchers noticed that the AD patient 
population displayed frequent periods of small nocturnal activity, further supporting the idea of 
fragmented and disrupted sleep cycles.  The main differences were observed when comparing 
locomotor activity levels.  However, there were minimal differences when analyzing core body 
temperature (CBT) rhythms, with a mean average higher in patients with AD than the controls. 
One encapsulating statement made towards the end of the journal article explains that the 
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combination of atypical temperature and locomotor activity levels, supplemented with 
fragmented sleep patterns, provides substantial evidence of loss of pacemaker function, and 
therefore disrupted circadian rhythms as well.  
One critique I would make on this article was actually brought to light by the researchers 
themselves.  They noted that there may have been environmental differences in the control 
patients that weren’t adapted to the hospital as a residence like the AD patients were.  These 
differences may have altered some results and findings of this particular experiment.  However, 
the researchers mention that for future related studies, they would take this information into 
account and plan an acclimation period for the control subjects prior to the start of a new study to 
eliminate as many differences between the two groups (Satlin et al., 1995). 
The third and final study pertaining to AD tests the impact of imposing bright light as a 
possible viable treatment for patients with the disease.  Specifically, this research article focuses 
on whether or not circadian cycles and rhythms could be shifted or corrected in patients with AD 
by imposing artificial external light.  Initial research into AD revealed that disordered circadian 
cycles may be attributed to loss of cells composing the SCN, thus diminishing its overall ability 
to function properly.  These deficits and  abnormalities are believed to be responsible for causing 
interrupted sleep cycles and sundowning behavior.  The research team hypothesized that bright 
light ‘pulses’ during evening hours prior to sleep would improve circadian rhythms as well as 
lessen agitation in those also displaying behaviors associated with sundowning. 
The study consisted of ten patients with AD, nine males and one female, with a mean 
average age of 70 years.  These patients were studied in the dementia unit of a veterans’ hospital 
for a period of three weeks.  All of the participants were deemed either moderately or severely 
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demented, with an average duration of AD illness of approximately 9 years.  All of the patients 
were under full time supervision of nurses.  The nurses analyzed the overall behavior of their 
patients at the end of each shift, three total times per day, and scored them on their level of 
agitation, ranging from zero to three.  A score of zero indicated none or minimal agitation, 
whereas a three indicated a severe level.  They also recorded the amount of restraint required to 
control the patients, and how frequently they needed to administer prescription medications to 
each patient.  Like the other two studies, locomotor activity was measured via a portable activity 
monitor worn in the pocket of a vest at about waist level.  All ten of the subjects were monitored 
and observed over a total period of three weeks.  The first week was to establish baseline 
measurements of the patients, the second week to test the hypothesized bright light treatment, 
and the third and final week for post-treatment observations.  During the second week in which 
treatment was provided, the subjects were exposed to two hours of bright light bursts from 
7:00-9:00 pm each evening of that week.  The light was delivered in the form of a light box 
which contained three U-shaped fluorescent bulbs. 
The researchers found that generally the light therapy helped improve sleep-wake cycles 
in eight out of the ten total participants, based on clinical ratings provided by the nursing staff. 
In the initial week intended for establishing baseline values, the mean score of the cycles among 
participants was rated 6.2/10.  After the second week in which treatment was provided, the 
scores dropped down to 3.0, and reaching lowest scores, averaging 2.3 at the end of the third 
week (post treatment values).  Generally, it was concluded that the bright light pulses resulted in 
improved sleep-wake behaviors in evening hours, decreased severity of the symptoms associated 
with sundowning, and reduced amounts of locomotor activity during evening.  The researchers 
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also mentioned that the locomotor activity acrophase was shifted approximately one full hour 
earlier at the end of the second and third weeks when compared with the baseline values. 
Although these results were not significant enough to make a conclusion for this particular study, 
further extensive testing over a longer period of time may prove to be a successful treatment 
option for AD patients (Satlin et al., 1992).  One major critique and concern I have regarding this 
study is related to the selected sample of participants.  It appears unusual that of the ten total 
selected participants, nine out of the ten were in fact men, with only a single woman 
participating.  This lack of a balanced or diverse sample may have sad some sort of impact on the 
recorded results of this study. 
Alzheimer’s disease is a complex progressive degenerative disease of the mind which has 
proven relationship with circadian cycles and functioning of the brain.  Generally, it was 
observed that patients with AD experience reduced amounts of daily activity and heightened 
amounts of nocturnal activity, a component of the disease which may be attributed to 
sundowning.  Specifically, when compared to healthy control subjects, the AD patients of the 
studies cited consistently expressed shifted cycles away from the norm, with later acrophases. 
Additionally, as the disease progressed in severity, patients displayed increasingly shifted cycles 
and later acrophases.  Findings were also consistent in suggesting that the impact of the disease 
is stronger in those who have been diagnosed with the disease for longer periods of time, with no 
correlation attributed to age.  One other noticeable trait of AD is a slightly elevated core body 
temperature when compared to healthy individuals.  These findings make sense when 
understanding the degree of neurodegeneration of the brain, specifically of the SCN and 
hypothalamus in general, the centers responsible for regulating homeostatic levels within the 
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body.  One encouraging discovery made was the possible future development of technology 
incorporating bright light as a form of treatment for patients with AD.  The artificially imposed 
bright light may be able to alter rhythms in such a way to reintroduce a sense of normalcy back 
to those impacted by the disease.  In turn, this form of therapy could also help reduce the severity 



















Parkinson’s Disease (PD) 
Parkinson’s Disease is a neurodegenerative disease, specifically impacting the substantia 
nigra of the brain.  The substantia nigra is located within the brainstem of the brain, specifically 
in the midbrain section.  It is primarily responsible for the production of the neurotransmitter 
dopamine via dopaminergic neurons.  In a healthy brain, the substantia nigra is described as a 
crescent-shaped cluster of darkly-pigmented cells.  As PD begins to take its course on the brain, 
these cells are gradually destroyed, resulting in lack of pigment upon visual examination in more 
severe and developed cases.  Dopamine is responsible for the control of movement and 
emotional responses of the human body, and in the presence of PD, the dopaminergic neurons 
are impaired, thus impacting movement.  
Substantia nigra of a healthy brain (left), and depigmentation of substantia nigra in PD brain 
(right) at 0.7 x magnification (Triarhou, “Dopamine and Parkinson’s Disease”). 
 
This disease is progressive and worsens in severity with time.  PD affects approximately one 
million individuals in the United States alone, and approximately ten million internationally. 
The majority of the affected population are typically of age 50 or older, however younger adults 
may also suffer from young-onset Parkinson’s disease (YOPD) and account for a total of 
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between two and ten percent of all cases within the U.S. alone.  ​Statistically, according to the 
CDC, complications associated with PD constitute the 14th leading cause of death in the United 
States.  The general cause of the disease is unknown, making it idiopathic in nature, and 
currently no cure exists.  However, there are treatment options available such as medications and 
surgery that can help treat certain associated symptoms (“What is Parkinson’s”, 2018). 
This disease in particular has a specific set of characteristic signs and symptoms, 
including but not limited to tremors, stiffness of the limbs, issues with gait or balance, and 
several others.  Additionally, in terms of non-motor symptoms, examples include cognitive 
changes, early satiety, excessive sweating, fatigue, hallucinations and delusions, mood disorders, 
sleep disorders, urinary frequency and incontinence, and vision loss.  While symptoms tend to 
develop slowly over years of being affected, an individual may be diagnosed with PD in more of 
a moderate stage rather than earlier and the disease may have already progressed to some degree. 
In order to analyze the progression of this disease, the Hoehn and Yahr scale was developed, 
which classifies the disease as a series of five different stages, respectively increasing in severity 
as you move up the scale.  In a general sense, the first and second stages are indicative of mild 
PD, the full third stage represents moderate PD, and the fourth and fifth stages constitute what 
would be considered severe PD.  The first stage is characterized by general unilateral 
involvement of the body and minimal impairment or deficits.  The main symptoms include 
tremor, rigidity, and poor condition in the arms or legs.  The face may also be affected on one 
singular side and pose resemblance to the condition of Bell’s palsy.  This stage is often missed 
entirely and a proper diagnosis of PD is typically made during a later phase.  After time has 
passed, in some cases months and others years, symptoms start to develop bilaterally, typically 
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indicating the origins of the second stage.  These may include bilateral loss of facial expressions, 
also known as masking, speech abnormalities, softer voice, slurred speech, generalized slowness, 
and rigidity of the trunk of the body.  Individuals at this stage are still capable of carrying out 
tasks of daily living.  If the symptoms are properly reflected bilaterally at this phase, it simplifies 
a PD diagnosis.  However, if the only symptoms at this point are rigidity and slowness, this 
phase may still be mistaken for typical adult aging.  The third stage, recognized as moderate PD, 
is generally characterized by an overall loss of balance and inability to react promptly to protect 
oneself from falling.  An individual may still be able to perform activities of daily independent 
living.  All other aspects of PD are present at this point enough to make a conclusive diagnosis of 
PD.  Also identified as the beginning of severe PD, stage four entails the disease being fully 
developed within the body.  The affected individual is still able to walk and stand unassisted, but 
clearly appears to be disabled and impaired.  The transition from the third to the fourth stage is 
marked by the inability of the individual to live and function on their own.   The fifth and final 
stage of PD is distinguished as the individual is typically confined to a wheelchair or 
permanently bedridden.  The individual is unable to rise or stand on their own, and are in greatest 
danger of falling as they are prone to freeze up when standing, as well as stumble when walking 
(“Five Stages of Parkinson’s”, 2018). 
Although the majority of the incidence of PD happens to be spontaneous and accounts for 
approximately 85 or 90 percent of all cases, the other 10-15 percent of cases are thought to occur 
genetically.  Scientists and researchers believe that in order to inherit PD, it is not simply a 
mutation of a singular gene that would result in the condition, but rather a complex interaction of 
multiple factors, even outside of the genetic realm.  For instance, there are also environmental 
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factors that may place individuals at higher risk of developing PD.  Some of these factors include 
but are not limited to age, gender, area of residence, occupation, pesticide or herbicide exposure, 
and several others (“What is Parkinson’s”, 2018).  
The first study pertaining to PD specifically focuses on the analysis of sleeping patterns 
in an attempt to define the circadian phenotypic expressions of individuals with early-stage PD. 
Prior to conducting their study, the research team noted that in a survey conducted of  nonmotor 
symptoms of Parkinson disease, 64 percent of participants reported suffering from sleep 
problems, the second greatest nonmotor complaint among PD patients.  This survey acted as the 
driving force for the team to conduct their own study, given their prior awareness of sleep 
problems linked to the presence of the disease, and the lack of general knowledge regarding the 
cause of the condition. 
The study consisted of an initial assessment with a total of 239 participants, further 
specified to a more comprehensive case-control subgroup of 45 individuals; 30 of which were 
diagnosed with early-stage Parkinson disease, and the other 15 acting as healthy control 
individuals.  In terms of data collection for the study, all participants were asked to keep sleep 
diaries, as well as wear an activity tracking monitor on their non-dominant wrist continuously for 
a period of two weeks prior to the sleep study.  The study itself entailed a polysomnographic 
assessment over two consecutive nights in which sleep patterns could be tracked and recorded. 
Patients were also equipped with a venous cannula to allow for blood collection without 
disturbing the sleep cycles of the subjects.  Other than getting up to go to the bathroom, the 
participants were asked to remain sedentary.  Meals were distributed to all participants at fixed 
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times, daytime naps were prohibited, and the temperature of the environment was maintained at a 
consistent 21 degrees celsius, or approximately 70 degrees fahrenheit.  
The researchers were able to reach several conclusions.  Patients newly diagnosed with 
PD were more likely to report frequent sleep complaints, which correlated with a general poorer 
quality of life when compared to controls.  The researchers noticed that the altered levels of 
circulating hormones in the body due to PD resulted in abnormal micro-shifts in sleep tendencies 
specific to PD patients.  These shifts include increased sleep latency, or the amount of time 
required for an individual to fall asleep, overall reduced efficiency of sleep, and reduced REM 
sleep when analyzing the sleep cycle as a whole.  Additionally, it was noted that the patients 
diagnosed with early-stage PD had a greater tendency towards hypersomnolence than controls. 
This means that the PD patients were more likely to experience excessive daytime sleepiness, or 
extended periods of sleep during the evening.  They also concluded that there was greater 
evidence of destructuring of sleep cycles in patients at more advanced stages of PD, supporting 
its progressive nature as a disease.  While declined activity of the SCN in healthy adults leads to 
sleep-wake disruptions and decreased production of melatonin, these effects are likely amplified 
and worsened for those with PD. 
This study supported hypotheses of disturbed sleep cycles in the presence of PD 
pathology, however more research should be conducted on this issue in order to better pinpoint 
causes and develop concrete treatments for the disease.  One major critique of this study would 
be that the number of participants in the sleep study (the major component for providing results 
and data for analysis) was relatively small.  Had this group of participants been larger, the 
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researchers would have possibly drawn the same conclusions,  but would have greater certainty 
of their findings as reflected by a larger target population  (Breen et al., 2014). 
The second study placed more of a focus on individuals with PD that experienced some 
degree of hallucinations as a side effect of the disease.  Specifically, it addresses the relationship 
between the presence of hallucinations in patients with PD and altered circadian rhythms.  After 
reviewing pre-existing literature, the research team noticed that some of the primary complaints 
of those with PD were related to sleep disturbances, however not much research had been done 
to investigate the relationship between the disease and circadian rhythms.  The researchers also 
believed that the pathology of PD on the body acts as a mechanism to expedite signs and 
symptoms that would typically develop and become more prominent with the passage of time 
and growing older naturally.  Before discussing their study, the researchers provided establishing 
background information to help familiarize the reader with the disease.  For example, they 
mention that PD is one of many degenerative diseases, and that it is comprised of sleep 
fragmentation and excessive daytime sleepiness, which paired together led themselves to altered 
biological rhythms.  
In this study, the researchers had two main hypotheses: first, that patients with PD would 
display altered rest-activity rhythms when compared to controls, and second, that a positive 
correlation was observed between the amount of disturbance and age as related to cognitive 
impairment.  The study consisted of 79 total participants.  50 of the total participants were adult 
PD patients, 27 of whom suffered from hallucinations, and 23 that did not have hallucinations. 
The remaining 29 individuals were healthy adult control subjects.  The controls did not report 
any neurological diseases, sleep disorders, or indications of dementia.  Periods of rest-activity 
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were measured using actigraph monitors, specifically uniaxial accelerometers, worn on the 
non-dominant wrists of the participants.  These devices were used to measure gross motor 
activity, and would provide the researchers with data about the participants’ periods of frequent 
motor activity.  The hallucinations were assessed with interviews conducted in which the 
researchers asked the participants questions about the frequency and subject matter of 
hallucinations they had experienced within three months prior to the study.  All data was 
recorded from the patients’ respective homes remotely, and all were instructed to carry out 
normal daily activities.  The participants were asked to wear the actigraph devices for one week 
and measurements were recorded at 30-second epochs.  
The research team found that all of the individuals with PD, both the standard and 
hallucinating forms,  had lower recorded peaks and bursts of activity when compared to the 
healthy control subjects.    These results likely reflect the fact that PD has debilitating effects on 
motion and movement, and therefore levels of activity would be expected to be lower than the 
average healthy individual.  Additionally, when comparing the frequency of activity of the PD 
patients against the controls, it was noted that the PD group had a greater tendency to often 
transition from high to low activity periods, making their activity levels less predictable than the 
average control individual.  The researchers also noticed that subjects with both PD and 
hallucinations had higher levels of activity and more fragmented sleep cycles than those that did 
not experience hallucinations.  Ultimately, the presence of PD was described as simply 
exaggerating the effects of normal aging on circadian rhythms, however at a quicker rate than a 
healthy control individual.  One constant connection the researchers of this study made was the 
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similarity in results of this PD study to other studies focused on AD, with the exception of the 
underlying pathologies of the respective diseases. 
Some possible problems with this particular study were discussed at the end of the article. 
First, the researchers mentioned that in order to treat some of the symptoms of PD, specific 
cycles and timing of treatment regimens were required, which may have imposed a pre-existing 
cyclical framework on these patients who they were trained to operate around.  In addition, due 
to the cognitive impairment and deficits of PD patients, it was difficult for proper compliance of 
the participants to maintain sleep diaries independently, some of whom did not have caretakers 
to help them (Whitehead et al., 2008).  
The third study mainly focused on the discovery of more information regarding the 
relationship between the presence of PD and its pathophysiological impact on biological 
circadian rhythms.  The research team wanted to investigate and analyze the endogenous 
secretion of the neurotransmitter melatonin in individuals affected by PD.  Prior to deciding to 
conduct their own study, the researchers found other experimentation conducted which indicated 
that subjects with PD suffered from a variety of skewed circadian rhythms and biological levels. 
The findings included fluctuations in blood pressure, heart rate, impaired sleep-wake cycles, and 
variations in cortisol and melatonin levels present.  From these discoveries, the researchers chose 
to conduct their own study with a specific focus on the impact of the disease on melatonin 
production, and its possible stimulation of excessive daytime sleepiness in PD individuals. 
The setup for this study consisted of a total of 35 participants.  20 individuals were 
patients with PD, and the remaining 15 participants served as control subjects.  Each of the 
control individuals were matched in age to their PD counterpart within the study.  The PD 
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patients were recruited from the Parkinson’s Disease and Movement Disorders Center of 
Northwestern University.  Contrastingly, the controls were recruited through advertising in the 
local Chicago area and the Aging Research Registry within the Northwestern Buehler Center on 
Aging.  Specific exclusion criteria were detailed in order to select specific participants for this 
study.  The criteria included a proper idiopathic diagnosis of PD as per the definition provided by 
the UK Parkinson’s Disease Society Brain Bank, ensuring the PD patients were between stages 
two to four on the Hoehn and Yahr Scale, and that they did not have either an atypical form of 
PD nor cognitive impairment or depression.  The same criteria, where applicable, was applied 
when selecting comparable control individuals.  This study uniquely took form as a 
cross-sectional study that was conducted between the dates of January 1, 2009 to December 31, 
2012.  The participants were asked to maintain a consistently regular sleep schedule for two 
weeks prior to the initiation of the study and to keep corresponding sleep journals as a physical 
record.  Participants were admitted to the clinical research unit at the Northwestern Memorial 
Hospital.  The participants were fitted with intravenous catheters in the forearm for ease when 
taking blood samples each half hour of a 24 hour period to analyze the blood serum hormone 
levels (specifically, assays for melatonin levels). 
Ultimately, the researchers were able to conclude that there were overall lower melatonin 
levels and amplitudes in the PD patients when compared to the control subjects.  Specifically, 
those patients that suffer from excessive daytime sleepiness exhibited the greatest amount of 
impairment in regards to circadian melatonin secretion.  This provided evidence for the 
importance of maintaining proper circadian cycles upon the manifestation of the symptom of 











The researchers noted that these results vary from other previous studies conducted, in which no 
difference in melatonin levels was found when comparing the PD patients to the control subjects. 
They attribute these possible differences to the fact that very different methods were used among 
the two studies to obtain the aforementioned results.  Additionally, the researchers noted that in 
their particular study, blood samples were obtained every half hour, compared to previous 
studies in which blood was sampled every one to two hours.  The greater frequency of sampling 
blood melatonin levels allowed the research team to obtain more accurate results and increased 
the ability of analyzing the timing of the melatonin rhythm (Videnovic et al., 2014). 
Generally, across the three PD studies, several conclusions were reached.  PD 
participants reported a generally poorer quality of life.  Immunoassay results revealed altered 
levels of circulating hormones in the body which resulted in shifts specific to PD pathology, 
including increased sleep latency, reduced efficiency of sleep, and reduced REM sleep. 
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Specifically, PD patients were observed as having lower blood serum melatonin levels and 
impaired melatonin secretion, providing an explanation for the physical manifestation of 
excessive daytime sleepiness in these individuals.  A positive correlation was observed between 
increasing destructuring of sleep cycles and the stage and severity of the disease.  Finally, 
analysis of actigraph monitored activity revealed that PD patients reported overall lower activity 
levels than controls.  This may be attributed to some degree of motor loss resulting from 


















Cancer can generally be described as the uncontrolled division of cells, forming 
malignant masses and destroying native body tissue.  It is a unique type of disease as it is able to 
affect virtually any system or organs of the human body.  Additionally, it has the potential to 
break off and spread throughout the body beyond the point of origin, a property known as 
metastasis.  In a normally functioning human body, old and damaged cells are typically broken 
down and replaced by healthy cells.  In the case of cancer, the old and damaged cells manage to 
survive, and new replacement cells are produced in excess where they are not needed.  The 
uncontrolled division and replication of these cells leads to tumorigenesis, the precursor of 
cancer.  
Looking at cancer in more of a general sense, it is a disease that is solely caused by 
genetics.  This means that genetic mutations or modifications may be inherited or passed down 
from biological parents.  On the other hand, genetic changes may arise over time as a result of 
either cellular errors upon division, or some environmental exposures including ultraviolet 
radiation emitted by the sun or inhaling tobacco smoke.  From one individual to another, cancer 
is unique in that it may contain any variety or combination of genetic alterations, and even within 
the same tumor, there may be different types of mutations.  In the cases of metastatic cancers, the 
secondary tumor is still named after the primary form, as it contains the same type of cells as the 
original form.  For instance, in the event that lung cancer should metastasize and travel to the 
brain, the secondary tumor would be identified as metastatic lung cancer rather than brain cancer.  
This disease is also known to take on a variety of prominent forms, detailed as the 
following.  Carcinomas are the one of the most common forms of cancer, which are formed by 
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epithelial cells, typically impacting either the skin of the lining of various internal organs. 
Sarcomas tend to take form in bone, muscle, fat, blood and lymphatic vessels, and other fibrous 
tissues like tendons and ligaments.  Leukemias originate in the blood-forming section of bone 
marrow, and are not manifested as physically solid tumors, but rather exist within the fluid of the 
blood space.  Lymphomas refer to cancer of lymphocytes, specifically in T cells and B cells. 
Multiple myeloma is the type of cancer that originates in plasma cells, and the abnormal cells 
accumulate in the marrow and form tumors.  Melanomas pertain to cancer of melanocytes, the 
pigment-producing cells of the body, and while they typically form on the skin, they can also 
form in other pigmented tissue areas including the eyes.  For the brain and spinal cord, the cancer 








Additionally for brain cancer, tumors may be either benign or malignant.  Although there are 
multiple different types of cancer, those that involve or are related to the brain are the most likely 
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to have a direct impact on the SCN, and ultimately the modification of circadian rhythms.  Brain 
cancer specifically can be designated as having either originated in the brain, also known as a 
primary tumor, or may spread to the brain from a different location, known as a secondary 
tumor.  Specifically for brain cancers, there is greater likelihood that they were formed as a result 
of metastasis from a different tumor as opposed to originating within the brain (“What is 
Cancer?”, 2015).  
As cancer is able to take on a variety of forms, this warrants the plethora of possible 
associated signs and symptoms.  Although the list of all cancer symptoms may be quite 
extensive, some of the most general and common include the following.  Individuals may 
experience changes of the skin, including the presence of new moles or spots, or open wounds or 
sores that do not appear to heal properly.  Additionally in terms of the skin, there may be 
hyperpigmentation and darkening of tissue, increased sensation of itching, and possible 
excessive hair growth.  There is the possibility of unexplained weight loss, typically a concern 
when the loss is ten or more pounds, and most commonly correlated with stomach, esophageal, 
pancreatic, or lung cancers.  Fever is also a common symptom of cancer, more likely to occur in 
the event of metastatic cancers, and can make it more difficult for the body to fight off infection. 
It is also quite common for these individuals to experience fatigue, and generally feeling more 
weakened and tired than normal.  Other more specific signs and symptoms that exist typically are 
associated with specific forms of cancer.  For instance, a change in bladder habits or function 
may be associated with either bladder or prostate cancer, a nagging cough a characteristic of lung 
cancer, and thickening of tissue or lumps forming in the body usually associated with breast or 
testicular cancers (“Signs and Symptoms of Cancer”, 2014). 
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When we hear cancer diagnoses discussed, there is also typically an assigned stage which 
identifies the degree of progression or aggression of the cancer.  Typically, doctors use the TNM 
system in order to describe what stage a cancer has taken.  TNM is an acronym, and its 
components assess the tumor, nodes, and metastasis of each individual case or incidence of 
cancer.  When analyzing the tumor as a whole, the criteria of focus pertain to both the size and 
location of the initial or primary tumor.  When providing numerical representation of the tumor, 
the letter “T”, accompanied by a number ranging from zero to four, is used to describe both the 
size and location of the tumor.  The second element is to see whether or not the cancer has 
managed to spread to the lymph nodes.  If this is the case, this section also involves searching for 
how many of the nodes have been compromised.  This information is represented by the letter 
“N”, paired with a number ranging from zero to three, in order to indicate the relative quantity of 
affected nodes.  The greater the amount of compromised nodes, the larger the number from the 
scale.  The final factor addresses the degree of metastasis throughout the rest of the body, and 
also contributes toward identifying possible secondary tumors.  The letter “M” is used to indicate 
metastasis, with “M0” representing no spread, and “M1” when the cancer has spread.  Another 
sector of staging consists of determining whether a case is in a clinical or pathological stage.  An 
individual diagnosed as having clinical stage cancer means that they were diagnosed as a result 
of tests, images, or scans, so long as they occurred before any surgical procedures.  On the other 
hand, an individual would be recognized as having pathological stage cancer if the discovery was 
made during a surgery.  Pathological staging better provides significant information in helping to 
decide on a prognosis when compared to clinical staging.  
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In addition to the TNM system, most cancers are generally acknowledged as having four 
distinct stages.  Occasionally, cancer may be recognized as being stage zero, in which the cancer 
is ​in situ​, or still located in its place of origin.  At this stage, cancer is plausibly treatable and can 
be easily removed fully with surgery.  Stage one is typically characterized by a small tumor in 
size that has not begun to spread into neighboring tissue, and often referred to as early-stage 
cancer.  Stages two and three are generally indicative of larger developed tumors that may have 
begun to grow into neighboring tissue and some lymph nodes, without spreading throughout the 
remainder of the body.  The final and most severe is stage four, in which the cancer has 
metastasized and spread beyond its point of origin to other locations within the body.  By this 
point, the cancer is referred to as advanced (“Stages of Cancer”, 2018). 
Currently, there are a variety of different treatment options to try and beat cancer.  One of 
the more popular treatment methods when appropriate is to undergo surgery.  A surgical 
procedure can be performed in order to debulk and remove a portion of a tumor, remove an 
entire tumor, or to correct symptoms of discomfort including pain or pressure.  Another 
treatment option comes in the form of radiation therapy, utilizing the same radiation that at low 
doses can be used to perform x-ray scans.  However, when being used to target cancer cells, a 
higher dose can be used to kill the malignant cells and shrink tumors.  One of the other options 
we commonly associate with the treatment of cancer is chemotherapy.  This method uses 
chemicals or drugs in order to target cancer cells, and can be given in a variety of ways including 
orally, intravenously, or topically.  Another viable option for treatment would be 
immunotherapy, in which biological substances produced by living organisms are used to 
enhance the body’s natural immunity in fighting cancer.  Targeted therapy is a more specific 
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option in which an individual case of cancer is analyzed in order to best decide how to attack the 
malignant cells.  This method seeks changes in the cancer cell that indicate how they mutate, 
grow, and spread, and are typically treated in the form of either small-molecule drugs or 
monoclonal antibodies.  The small-molecule drugs are best used to enter the cell, whereas the 
monoclonal antibodies attach to specific markers on the outer surface of the cells.  Hormone 
therapy, also known as endocrine therapy, is a form of treatment that attempts to halt or 
terminate the growth of cancer cells which utilize hormones, and typically is used to treat cases 
of both prostate and breast cancers.  Stem cell transplants may also be used as a viable method 
for cancer treatment in order to replace blood-forming cells necessary to have a properly 
functioning immune system, and the best chance at fighting the cancer.  These stem cells may be 
harvested from the individual themself, or may be donated from a different individual, not 
necessarily related by blood.  The final method is known as precision or personalized medicine, 
in which doctors hand-pick a combination of specific treatments to target the genetic makeup for 
each unique case (“Types of Cancer Treatment”, 2017).  Many of these methods can be quite 
costly, and specific forms of cancer still require many years of research and testing in order to 
find proper definite remedies. 
The first source related to cancer focuses mostly on the general relationship between 
cancer cells and their impact on circadian rhythm as they alter natural processes of human 
physiology.  Scientists are aware that in order for tumors to grow and develop, excess amounts of 
nucleic acids and proteins must be produced in order to prepare for the replication of cellular 
matter.  While the protein synthesis is rapidly increasing, there are a certain percentage of 
proteins that will not be properly folded.  These malformed cells trigger the unfolded protein 
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response (UPR) which acts by slowing new protein synthesis in order to properly fold the 
misshapen proteins.  The intriguing factor came from the discovery that cancer cells learned how 
to take advantage of the UPR mechanism and process of delaying protein synthesis in order for 
them to thrive in otherwise quite toxic situations.   It is known that the UPR and circadian 
rhythms are somehow linked to one another, however it was not known what the exact 
relationship between the two was.  J. Alan Diehl, Ph.D. and colleagues, from the MUSC 
Hollings Cancer Center, conducted a series of experiments in order to learn more about the 
correlation between cancer pathology and circadian cycles.  These experiments utilized both 
human and rat subjects, the human participants simply being observed, and the rats as test 
subjects which were provided experimental treatment in order to identify modifications.  
The group’s main question before going into the experiments was whether the misfolded 
proteins themselves may alter circadian rhythm of cancer cells.  In their first set of experiments, 
the research team used chemicals to induce the UPR mechanism in osteosarcoma cells. 
Researchers concluded from these experiments that when activated, the UPR mechanism 
impacted levels of a protein known as Bmal1, a transcription factor that fluctuates depending on 
environmental expression of relative light or dark.  Specifically, the Bmal1 levels remained low 
during periods of both light and dark, and as a result shifted circadian cycles.  This would 
indicate that the compromised UPR mechanism was modified in favor of the cancer cells, but 
resulted in the inability to discern between day and night and respond accordingly.  In order to 
support their findings, they conducted a follow-up experiment in which the main parts of the 
UPR mechanism were removed from the cancerous cells.  Upon this trial, the phase shift did not 
occur.  
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In the next set of experiments, the researchers investigated the manipulated UPR 
mechanism in a group of rats.  Essentially, this round of experimentation revealed that the UPR 
process acts almost as an intermediate liaison between the processing of light and dark cycles, 
and is essentially responsible for establishing stable circadian cycles.  Again, the researchers 
were able to note that as the levels of the Bmal1 protein decreased, the UPR was increasingly 
activated, similar to what was observed from the first set of experiments.  In order to verify their 
results, the researchers conducted another round of experiments in which the rats were subjected 
to a sudden reverse of their light and dark cycles.  As a result, their levels of Bmal1 were no 
longer fluctuating, but rather reaching a point of consistency.  
Between both of the sets of experiments, the research team was able to reach some 
valuable conclusions.  First, they identified a relationship between UPR and Bmal1 protein 
production which is greatly influenced by varying light and dark cycles.  Additionally, they 
concluded that UPR itself may have an impact on causing phase shifts in circadian genes and 
ultimate biological expression.  Finally, the researchers deemed UPR responsible for causing the 
overall loss of Bmal1 proteins, allowing for rampant tumor growth and providing a favorable 
environment for cancerous cells to thrive within the body (Medical University of South Carolina, 
2017). 
The second source related to cancer takes the form of a scientific review by Christos 
Savvidis and Michael Koutsilieris, scientists studying endocrinology and metabolism, as well as 
physiology.  These scientists reviewed a vast quantity of previously conducted studies regarding 
components of the relationship or link identified between circadian rhythms and cancer. It is 
mentioned that both standard healthy cells, as well as pathogenic cancer cells, maintain circadian 
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time and are regulated by their expression of similar clock genes.  Additionally, when analyzing 
epidemiological studies, it was discovered and correlated that there was greater incidence and 
poorer prognosis of breast cancer in populations with distorted circadian cycles. 
From the compiled studies, the researchers of this article concluded that the disruption of 
circadian rhythms was present in a variety of different cancer forms.  They also mention that 
there is increasing evidence being discovered to further solidify the relationship between cancer 
pathogenesis and dysfunction observed within circadian cycles.  For instance, one of the many 
studies detailed the pathogenesis of prostate cancer.  That particular population-based 
case-control study detailed that there was evidence of a link between modified circadian genes 
and the development of prostate cancer.  In the normally functioning male human body, clock 
genes and androgen receptors are expressed with typical circadian cycles.  However, when 
circadian clock genes such as ​Per1​ are improperly functioning, they block the androgen 
receptors which may be associated with the initiation of cancer within the prostate.  
The authors of this source also drew several other significant conclusions after analyzing 
all of the studies.  They stated that a portion of cancer cell growth is due in part to clock gene 
regulation of the human body, and that unregulated clock genes also contribute to progression, 
metastasis, and angiogenesis of various forms of cancer.  When specifically investigating the 
relationship between melatonin levels and cancer, the authors also arrived at some conclusions. 
For example, one of the studies made a great discovery from activating melatonin receptors in 
patients with breast cancer.  The increased melatonin levels inhibited the process of transduction, 
the transfer of foreign DNA into native cells, among cancer cells.  The process helped contain 
the growth of a cancerous tumor.  Additionally, a separate study discussed that in patients with 
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untreated non-small-cell lung cancer, measured levels of both melatonin and cortisol were lower 
than expected of a healthy individual, suggesting some degree of neuroendocrine dysfunction 
within the brain.  The properly functioning endocrine system would assess the needs of the body, 
and regulate hormone levels accordingly.  When the system is disrupted, the hormone levels are 
in turn impacted and unable to be properly regulated. 
The authors of this source conclude that there is likely some sort of  relationship between 
improper regulation of clock genes and disrupted circadian cycles and the encouragement of 
cancer pathogenesis (Savvidis and Koutsilieris, 2012).  As we have turned to adapting more 
modern lifestyles, humans have begun to induce circadian disruptions by introducing external 
sources of light at nighttime, and some interactions between our genes and ever-changing 
environment.  Hopefully, with this new information, we will one day be able to create more 
efficient and specific remedies to eradicate certain forms of cancer. 
The third source shifts focus more towards how psychosocial effects impact cancer 
growth and development, and in turn create an impact on natural circadian cycles.  As mentioned 
in the abstract, the more severe the incidence or case of cancer, the more likely an individual will 
experience greater disruption of circadian rhythms.  Specifically, the disruptions may take the 
form of complete phase shifts, altered amplitudes of activity, and inconsistent peaks and troughs 
of various endocrine, metabolic, immunological, and rest-activity cycles. 
One specific section of this journal article details observations made from a collection of 
studies regarding the relationship between circadian rhythms and cancer incidence.  One of the 
larger findings provided a link between increased risk of developing breast cancer after working 
extended nighttime shifts of a job.  The hypothesis of the study suggests that the exposure to 
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light during late evening time leads to the suppression of anticipated naturally-produced 
melatonin.  With the presence of melatonin in the body, a typical response in women is to 
withhold estrogen production.  In the absence of melatonin to act as a regulating mechanism, 
excessive estrogen is produced, likely resulting in a higher incidence of breast cancer. 
Additionally, shift work forces an individual to alter their typical rest-activity cycle in order to 
adapt to working conditions.  This imposed shift of a circadian cycle is also likely responsible for 
encouraging cancer development.  
The next important section discusses the relationship between circadian rhythms and 
cancer progression.  It was observed that in patients with breast, prostate, ovarian, stomach, and 
colon cancers, the disruption of circadian cycles was evident across multiple body systems.  For 
instance, the endocrine system is impacted by modifying the levels of cortisol, melatonin, 
prolactin, thyroid stimulating hormone, growth hormone, luteinizing hormone, and follicle 
stimulating hormone.  Metabolic levels, including temperature, proteins, and enzymes, as well as 
immunological rhythms are also modified, with greater level of disturbance in more severe cases. 
These markers may serve as indicators of the status of a tumor and provide healthcare 
professionals with useful information when assessing their patient.  Other mentioned prospective 
studies have analyzed the ability of using circadian rhythms as a possible indicator of cancer 
prognosis.  For instance, one study researched the link between the relative presence of natural 
killer (NK) cells and the progression of breast cancer cases.  NK cells have the ability to kill 
cancerous cells, however as their cytotoxicity decreases, there was an observed correlated rise in 
breast cancer development.  
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With final remarks, the authors also mention that disrupted circadian cycles reduce the 
efficiency and potency of some cancer treatments (Sephton and Spiegel, 2003).  Based on 
observations and recorded patterns of unique cycles of individuals, practitioners are able to 
precisely administer cancer treatments during periods when toxicity will be at its lowest, and 
efficiency at its highest in order to give the patient the best possible treatment.  A better 
understanding of the relationship between circadian cycles and their altered timing under the 
control of cancer is crucial in understanding how to approach treatment, whether a psychosocial 
or biomedical intervention. 
The fourth and final source provides substantial general information regarding 
components of circadian regulation and their importance, followed by how the factors are 
modified or impacted with the presence of cancer.  Specifically, this source focuses on 
hematopoietic and hormone-related malignancies that give rise to breast and prostate cancers. 
Hematopoiesis is the biological process in which new blood cells are formed from stem cells. 
When circadian rhythms are normal, hematopoiesis functions properly with the successful 
creation of new blood cells.  However, if levels of the ​Per​ clock genes are lower than required to 
function, this process is disrupted.  The suppression of ​Per​ genes can be observed in a variety of 
leukemias and lymphomas.  As these genes are restrained, circadian cycles are impaired which 
could be a potential source for encouraging cancerous growth.  Due to their unassigned nature, 
we may be able to develop a form of cancer treatment in which stem cells can be used to 
specifically target malignant cancerous material.  
Many endocrine and metabolic hormones are regulated by a variety of circadian cycles 
which depend on  daytime and nighttime fluctuations.  Therefore, an increasing amount of 
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studies provide evidence of a link between circadian modifications and endocrine malignancies. 
Most notably, a number of epidemiological studies have formed a clear connection between 
circadian disruption and increased risk of developing breast cancer.  In breast cancer cases, it is 
noted that there are identified mutations in both the ​Per1​ and ​Per2​ genes, which provides 
grounds indicating altered circadian cycles which may lead to tumorigenesis.  Additionally, 
similar mutations and reduced quantities of the crucial ​Per​ clock genes were widely observed 
across many instances of prostate cancer from epidemiological studies.  Less is known about the 
impact of altered clock genes in males impacting the prostate when compared to the incidence of 
breast cancer, however the foundational causes appear to be similar (Gery and Koeffler, 2010). 
Among the multiple studies related to cancer, multiple conclusions were drawn. 
Regarding the UPR mechanism, some cancer cells gained the ability to utilize the process in 
order to develop and thrive in situations that would otherwise be toxic, rendering the cancer cells 
ineffective.  Additionally, the UPR mechanism itself has an impact on causing phase shifts in 
circadian genes and their biological expression.  In general, circadian dysregulation may also 
result in the reduced effectiveness of various cancer treatments.  Finally, unregulated clock 
genes, such as the ​Per ​genes, can contribute towards the progression, metastasis, and 








Blindness can be defined in a variety of different technical ways, but as a general 
statement, it entails an individual that experiences some degree of vision loss.  As compared to 
the previous illnesses discussed, blindness differs in that this type of impairment is associated 
with the loss of a sensation, as opposed to a direct internal pathological condition.  Vision loss 
itself may described in either one of two ways: partial or complete.  An individual with partial 
vision loss entails that they have a very limited percentage of vision, yet are still somewhat able 
to see.  On the other hand, complete vision loss indicates that an individual is not able to see 
anything at all, including perception of light or darkness of the surrounding environment.  Vision 
loss may also happen suddenly, or may progressively worsen over time.  An individual may be 
blind at birth if they are born prematurely, however majority of cases are acquired or develop 
with age or other circumstances.  Specifically, majority of visually impaired  individuals are over 
the age of 50.  By definition of the law of the United States, an individual is deemed legally blind 
if their vision is worse than 20/200 with the aid of either glasses or contact lenses.  This means 
that the person in question would be able to see at 20 feet what a normal person can see from 200 
feet away.  It is estimated that globally 1.3 billion people have some degree of visual impairment 
as of current time (“Blindness and Vision Loss”, 2016; “Vision Impairment and Blindness”, 
2018). 
There are multiple different causes of blindness, however the most common include 
cataracts, age-related macular degeneration, glaucoma, and diabetic retinopathy.  A cataract is 
typically defined as when the lens of the eye, which is typically transparent, develops a layer of a 
cloudy film across its surface.  This film in turn blocks and impacts the amount of light necessary 
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for proper visual transmission of one’s surroundings.  In standard physiology, the role of the lens 
is to focus the perceived light against the retina in the interior of the eye in order to transmit 
visual information.  In the case of cataracts, the cloudy appearance of the lens casts a blurry light 
against the retina wall, producing a perceived blurry vision of the environment.  Next, we have 
age-related macular degeneration which specifically impacts and blurs the central sector of the 
field of vision.  This type of visual impairment comes in two forms: wet and dry.  In its wet 
form, leaky blood vessels grow underneath the surface of the retina.  On the other hand, dry 
macular degeneration entails the deterioration of the center of the retina itself.  Glaucoma is an 
overarching name for a group of diseases related an increase of pressure in the eye, resulting in 
distorted and impaired vision.  Specifically with glaucoma, one’s vision appears as if they are 
viewing their surroundings through a tunnel of sorts, with a blurred and darkened vignette 
around the perimeter of the field of view, and with potential to worsen or even darken over time. 
Finally, diabetic retinopathy indicates an eye disease in which the blood vessels of the retina are 
impacted.  The pathology of diabetes renders the small blood vessels of the retina weak, causing 
possible occlusion or even deterioration.  With the ever-growing prevalence of acquired diabetes 
in middle-aged adults, there is correspondingly a rise in prevalence of diabetic retinopathy 
among this population.  Beyond these four primary causes, other possible but less likely causes 
include surgical complications, tumors, strokes, and several others (“Blindness and Vision 
Impairment”, 2017).  In terms of diagnosis, various forms of visual impairment of blindness can 
be recognized in dilating the eyes during an examination in order to assess various components 
including the cornea, lens, and retina.  On the next page are manipulated depictions of what an 













These photographs depict what a typical field of view would appear as under normal 
circumstances, as well as for individuals with cataracts, age-related macular degeneration, 
glaucoma, and diabetic retinopathy (“Eye Disease Simulations”, ​National Eye Institute of NIH​)​. 
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The first source related to blindness investigates the relationship between disrupted 
circadian sleep cycles in blind individuals, as well as possible treatment with supplemental 
melatonin.  For blind individuals, visual cues cannot be transmitted from the retina of the eye to 
the brain, resulting in an impaired circadian clock, and in turn, disrupted biological rhythms. 
Without the proper transmission of visual information, it becomes difficult for the body to 
synchronize its daily physiological activity and behaviors.  Although a variety of components 
contribute to the maintenance of regulated circadian rhythms, one of the primary and most 
evident shifts is observed with either the presence or absence of light in the surrounding 
environment.  
One of the studies discussed findings that in their blind subjects, a majority had 
developed their own abnormally entrained circadian rhythms, or completely shifted to 
free-running rhythms.  The same study also provided a relationship indicating that the greater the 
severity of the visual impairment or loss of vision, the more abnormal their respective circadian 
cycles were.  Another study consisted of 388 blind subjects provided results indicating more 
disturbed sleep cycles in those with a total loss of light perception when compared with 
individuals having only some degree of perceived light.  Another interesting point mentioned 
was that in the individual with abnormal circadian rhythms, more daytime naps were taken than 
when compared with control subjects having normal circadian cycles.  A likely explanation is 
attributed to the brain’s inability to properly discern between daytime and nighttime, placing the 
body in a state of fatigue as it struggles to adapt to some form of abnormal rhythm.  The general 
fatigue would provide a reasonable explanation for the increasing amount of naps taken. 
Although differences were noted between blind individuals when compared to visually-able 
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control subjects, and even among varying degrees of severity of visual impairment, none of the 
studies noted any significant differences between those suffering from congenital blindness when 
compared to those with acquired blindness.  
One of the other crucial components discussed in this particular source is related to the 
use of external melatonin as a possible treatment to regulate circadian cycles.  Depending on the 
timing on when it is dispensed, the provision of administered melatonin can either advance or 
delay the timing of the circadian clock of the human body.  The authors of this source mention 
how studies in relatively recent years successfully entrained individuals with free-running 
rhythms by implementing the use of supplemental external melatonin.  Additionally, the use of 
melatonin for this sort of therapy was also proven to improve sleep and reduce the amount of 
daytime naps taken by visually impaired individuals.  With this information, the hope is for 
researchers to develop a more established form of treatment to reduce some of the inconvenient 
symptoms associated with abnormal circadian cycles (Skene and Arendt, 2006). 
Most totally blind individuals experience free-running rhythms that are out of sync with 
those that would be considered normal, resulting in insomnia and daytime sleepiness.  For these 
individuals, rhythms essentially need to be reset in order in order to follow a more true 24 hour 
cycle.  The study was described as a “crossover study”, in which the participants were provided 
different treatments over a period of time.  
In specific terms of the experimental design, seven subjects were selected as participants 
and were deemed completely blind after an ophthalmologic examination.  These individuals also 
were specifically selected because they had free-running cycles, a key component of the study. 
Other than being blind, the subjects were relatively healthy individuals.  Upon random selection, 
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half of the participants were selected to receive ten milligrams of melatonin, while the other half 
received a placebo, with both pills being administered approximately one hour before the 
specified bedtimes of the patients.  This system remained in place for approximately  one 
montht, varying depending on each subject’s free-running cycle.  Measurements of melatonin 
levels were taken on chosen days via blood samples every hour for a full 24 hours, and additional 
melatonin would not be supplied these days as to not skew the results.  Additionally, sleeping 
patterns were recorded via polysomnography. 
Ultimately, the researchers found that, with cycles averaging approximately 24.5 hours in 
a 24 hour period, the individuals given the placebo were completely unaffected.  For these 
individuals, the cycles were still free-running as anticipated.  However, in six of the seven 
subjects that received the supplemental melatonin, circadian rhythms were  entrained, and the 
subjects were able to sleep more efficiently.  These subjects spent less time overall awake after 
the initial onset of sleep in the evening.  The efficiency and quality of sleep was improved with 
melatonin treatment.  After the initial study, three of the original subjects participated in another 
trial which provided the same ten milligram supplement of melatonin on a daily basis until 
entrainment was achieved.  At that point, the dose was reduced to simply half a milligram daily 
for a period of three months.  Even after the drastic reduction in the dose of the melatonin 
supplement, the entrainment still persisted. 
This experiment provided crucial findings linking the provision of supplemental 
melatonin and entrainment of free-running circadian cycles in completely blind individuals 
(Brandes et al., 2000).  One major critique I have of this study would be that the sample size was 
relatively small.  Although I do understand that the small sample size allowed the researchers to 
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specifically analyze the changes and modifications of rhythms in each of the individual subjects, 
it would be in their best interest to replicate this study on a larger scale with more participants to 
substantially support their results. 
Between the sources pertaining to blindness, we were able to learn important information. 
For instance, in visually impaired individuals, specifically prominent in those completely blind, 
free running rhythms occur, which are out of sync with standard rhythms, resulting in insomnia 
and increased tendencies of daytime sleepiness.  As visual cues cannot be easily transmitted from 
the retina to the optic nerve and eventually the brain, one’s lack of visual perception of their 
surroundings results in an impaired circadian clock.  Additionally, these sorts of erratic or altered 
cycles can be treated with supplemental melatonin in order to normalize cycles and return to 
resemble a standard 24 hour cycle.  Finally, although both groups were deemed equally blind, no 












Findings of Huntington’s Disease 
In the process of preparing material for this thesis, I also collected research pertaining to 
Huntington’s disease (HD) as a fifth pathological factor for discussion.  Although this disease 
will not be discussed in full detail, I found it important to relay my findings.  The three sources I 
gathered pertaining to Huntington’s disease ended up providing similar results as those 
concluded from Alzheimer’s disease and Parkinson’s disease.  Specifically, they recounted that 
under the pathology of HD, changes were observed notably in the SCN of the hypothalamus, the 
master circadian pacemaker of the body, similar to AD.  HD patients also displayed greater 
daytime dysfunction and delayed sleep onset  when compared to controls.  In addition to the 
shifted acrophase of sleep, it was also generally observed that HD patients were significantly 
more active during nighttime when compared to controls.  Under a more physiological lens, one 
of the studies specifically focused on the levels of melatonin in HD patients, and reported that 
HD patients had lower recorded plasma melatonin levels than their respective control 
counterparts.  Finally, in similar fashion shared by both AD and PD, HD patients reported greater 









Comparison and Conclusion 
After analyzing studies pertaining to the four different diseases, it is evident that they 
each have some degree of impact on circadian rhythms and cycles within the body.  The findings 
under Alzheimer’s disease and Parkinson’s disease were similar in that they both resulted in 
lower recorded amounts of daily activity and general fatigue.  Additionally, it was characteristic 
of both of the diseases to display increasing severity of circadian disruption with the progression 
of the diseases respectively.  The findings from both of the diseases were also found and briefly 
mentioned as similar to those of Huntington’s disease.  On the other hand, the effects of cancer 
on circadian rhythms took more of an internalized toll across the body rather than just the brain 
specifically, as was the case for both AD and PD.  Cancer was unique in that the pathological 
cells learned how to take advantage of the body’s natural biological processes in order to thrive 
and grow in otherwise quite toxic environments.  Finally, with blindness and the loss of visual 
sensation or visual impairment, the pathway of processing observed external stimuli was absent, 











Acrophase:​ Indicative of a peak point or crest of a recorded cycle. 
 
Chronobiology:​  A word of Greek origin, derived from the words ‘chronos-’ meaning time, and 
biology, the study of living things.  A subsector in the field of biology, specifically focused on 
inspecting and analyzing the cyclical patterns resulting from living organisms and their responses 
to both solar and lunar rhythms.  
 
Circadian:​ A word of Latin origin, the definition can be broken down into two fragments.  The 
first being ‘circa-’, translating to “about”, and the second piece ‘dies-’ meaning “day”, providing 
a general unified definition of something that occurs within the period of one full day.  
 
Diurnal:​ An alternate word indicative of an event or pattern that occurs during the day.  These 
events differ from circadian events in that they vary with time of day.  Additionally, they may 
either be light driven or clock driven, allowing for the variable factor of time. 
 
Endogenous:​ An adjective indicating something of internal origin.  In a biological context, 
something endogenous can range from microscopic substances at the cellular level, or may be as 
complex as various internal mechanisms or processes. 
 
Entrainment:​ A phenomenon dependent on environmental oscillation and cues.  A process that 
occurs to optimally achieve synchronicity among various processes or behaviors within a single 
being.  With respect to studies focused on circadian rhythms, a modification or alteration of 
either a phase or period of circadian cycles as a result of exposure to external light. 
 
Free-running:​ A sleep pattern not properly entrained to a natural 24 hour cycle. 
 
Melatonin:​ A hormone commonly associated with inducing the sensation of sleep. 
 
Substantia Nigra: ​ ​Located within the brainstem of the brain, specifically in the midbrain section, 
and is primarily responsible for the production of the neurotransmitter dopamine via 
dopaminergic neurons. 
 
Sundowning:​ A phenomenon generally describing heightened intervals of active behavioral 
symptoms, especially during afternoon and evening periods in a day. 
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Suprachiasmatic Nuclei (SCN):​ commonly referred to as the “master clock”, this section of the 
hypothalamus of the brain forms a connection between the nervous and endocrine systems, and 
is responsible for overseeing all mechanisms and rhythms for all cells of the human body. 
 
Zeitgeber:​ A word of German origin, and formally acknowledged as the combination to two 
other individual German words.  The fusion of both ‘zeit’ meaning time, and ‘geber’ meaning 
giver literally translates to ‘giver of time’.  With contextual relevance to this thesis, this word is 
representative of natural or environmental cues provided by one’s surroundings.  For instance, 
shifts between periods of lightness to darkness, or temperatures from warm to cool, function as 
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